Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice

被引：34

作者：

Hambach, L

Nijmeijer, BA

Aghai, Z

van Schie, MLJ

Wauben, MHM

Falkenburg, JHF

Goulmy, E

机构：

[1] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands

[2] Leiden Univ, Med Ctr, Dept Haematol, Leiden, Netherlands

来源：

LEUKEMIA | 2006年 / 20卷 / 02期

关键词：

D O I：

10.1038/sj.leu.2404056

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：371 / 374

页数：5

共 8 条

[1] CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells [J].

Bonnett, D ;

Warren, EH ;

Greenberg, PD ;

Dick, JE ;

Riddell, SR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8639-8644

[2] Immunotherapy of cancer through targeting of minor histocompatibility antigens [J].

Hambach, L ;

Goulmy, E .

CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (02) :202-210

[3] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS [J].

KOLB, HJ ;

SCHATTENBERG, A ;

GOLDMAN, JM ;

HERTENSTEIN, B ;

JACOBSEN, N ;

ARCESE, W ;

LJUNGMAN, P ;

FERRANT, A ;

VERDONCK, L ;

NIEDERWIESER, D ;

VANRHEE, F ;

MITTERMUELLER, J ;

DEWITTE, T ;

HOLLER, E ;

ANSARI, H .

BLOOD, 1995, 86 (05) :2041-2050

[4] Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia [J].

Marijt, WAE ;

Heemskerk, MHM ;

Kloosterboer, FM ;

Goulmy, E ;

Kester, MGD ;

van der Hoorn, MAWG ;

van Luxemburg-Heys, SAP ;

Hoogeboom, M ;

Mutis, T ;

Drijfhout, JW ;

van Rood, JJ ;

Willemze, R ;

Falkenburg, JHF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2742-2747

[5] Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens [J].

Mutis, T ;

Verdijk, R ;

Schrama, E ;

Esendam, B ;

Brand, A ;

Goulmy, E .

BLOOD, 1999, 93 (07) :2336-2341

[6] An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice [J].

Nijmeijer, BA ;

Willemze, R ;

Falkenburg, JHF .

BLOOD, 2002, 100 (02) :654-660

[7] Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice [J].

Verra, NCV ;

Jorritsma, A ;

Weijer, K ;

Ruizendaal, JJ ;

Voordouw, A ;

Weder, P ;

Hooijberg, E ;

Schumacher, TNM ;

Haanen, JBAG ;

Spits, H ;

Luiten, RM .

CANCER RESEARCH, 2004, 64 (06) :2153-2161

[8] Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells [J].

Yee, C ;

Thompson, JA ;

Byrd, D ;

Riddell, SR ;

Roche, P ;

Celis, E ;

Greenberg, PD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) :16168-16173

← 1 →